News | June 14, 2021
Lupin receives warning letter from U.S. FDA
The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility
The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility
These five oxygen plants with a total capacity of 3,840 cubic meters of oxygen per day have been donated to Madhya Pradesh, Maharashtra, and Gujarat
The new platform is the latest initiative under Lupin’s long running umbrella programme, Joint Airways Initiative (JAI), for patients suffering from respiratory ailment
Emtricitabine and Tenofovir Disoproxil Fumarate tablets had estimated annual sales of US $2.1 billion in the U.S. according to IQVIA MAT March 2021
Arformoterol Tartrate Inhalation Solution is for treatment of bronchoconstriction
The company recently incorporated a new entity in the name of Lupin Digital Health Limited
Pegfilgrastim has estimated annual sales of USD 3.66 billion in the U.S. (IQVIA MAT December 2020).
MEK inhibitor compound (LNP3794) developed as part of its oncology pipeline had previously shown pre-clinical activity as a single agent as well as in combination
It reported total income of Rs.15299.25 crores during the FY ended March 31, 2021
Baricitinib is an oral medication that was earlier registered in India for the treatment of moderate to severe active rheumatoid arthritis in adult patients.
Subscribe To Our Newsletter & Stay Updated
